Clinical trial

Randomized, Double-blind, Placebo-controlled, Multicenter, Cross-over Study to Assess the Effects of a 3 Week Therapy Each With QVA149 Versus Placebo on Pulmonary Function and Average Physical Activity Levels in Patients With COPD.

NCT01996319

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-04-01

PhasePHASE3

Study timeline

Study start (unknown)2014-04-01Date precision: month

Registry last updated2016-04-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Diseaseunresolved

Interventions

QVA149DRUG

PlaceboDRUG

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

BerlinGermany2 LeipzigGermany2 LübeckGermany2 HamburgGermany1 CologneGermany1 MünsterGermany1 ErlangenGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01996319 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.